{"id":"https://openalex.org/W2015339598","doi":"https://doi.org/10.1002/jmv.21438","title":"Randomized trial of high\u2010dose interferon\u2010\u03b1\u20102b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy","display_name":"Randomized trial of high\u2010dose interferon\u2010\u03b1\u20102b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy","publication_year":2009,"publication_date":"2009-02-23","ids":{"openalex":"https://openalex.org/W2015339598","doi":"https://doi.org/10.1002/jmv.21438","mag":"2015339598","pmid":"https://pubmed.ncbi.nlm.nih.gov/19235866"},"language":"en","primary_location":{"id":"doi:10.1002/jmv.21438","doi":"https://doi.org/10.1002/jmv.21438","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jmv.21438","pdf_url":null,"source":{"id":"https://openalex.org/S49828768","display_name":"Journal of Medical Virology","issn_l":"0146-6615","issn":["0146-6615","1096-9071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Virology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102143879","display_name":"Nami Mori","orcid":"https://orcid.org/0000-0001-8589-6560","observed_orcids":["https://orcid.org/0000-0001-8589-6560"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nami Mori","raw_affiliation_strings":["Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022484621","display_name":"Michio Imamura","orcid":"https://orcid.org/0000-0002-0745-991X","observed_orcids":["https://orcid.org/0000-0002-0745-991X"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michio Imamura","raw_affiliation_strings":["Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113824353","display_name":"Yoshiiku Kawakami","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiiku Kawakami","raw_affiliation_strings":["Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048673628","display_name":"Hiromi Saneto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiromi Saneto","raw_affiliation_strings":["Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031469873","display_name":"Tomokazu Kawaoka","orcid":"https://orcid.org/0000-0002-1887-1096","observed_orcids":["https://orcid.org/0000-0002-1887-1096"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomokazu Kawaoka","raw_affiliation_strings":["Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112553834","display_name":"Shintaro Takaki","orcid":"https://orcid.org/0000-0002-8492-5339","observed_orcids":["https://orcid.org/0000-0002-8492-5339"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shintaro Takaki","raw_affiliation_strings":["Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037963685","display_name":"Hiroshi Aikata","orcid":"https://orcid.org/0000-0002-3409-2156","observed_orcids":["https://orcid.org/0000-0002-3409-2156"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Aikata","raw_affiliation_strings":["Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109890395","display_name":"Shoichi Takahashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shoichi Takahashi","raw_affiliation_strings":["Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023958825","display_name":"Kazuaki Chayama","orcid":"https://orcid.org/0000-0002-5530-5341","observed_orcids":["https://orcid.org/0000-0002-5530-5341"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kazuaki Chayama","raw_affiliation_strings":["Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan","institution_ids":["https://openalex.org/I113306721"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023958825"],"corresponding_institution_ids":["https://openalex.org/I113306721"],"apc_list":{"value":4730,"currency":"USD","value_usd":4730},"apc_paid":null,"fwci":4.0768,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.93879213,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"81","issue":"4","first_page":"640","last_page":"649"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9950000047683716},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9459999799728394},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9649999737739563},{"id":"https://openalex.org/keywords/high-dose-interferon","display_name":"high-dose interferon","score":0.9620000123977661},{"id":"https://openalex.org/keywords/core-protein","display_name":"core protein","score":0.39100000262260437},{"id":"https://openalex.org/keywords/ns5a","display_name":"NS5A","score":0.9430000185966492},{"id":"https://openalex.org/keywords/amino-acid-substitutions","display_name":"amino acid substitutions","score":0.9829999804496765},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.9459999799728394},{"id":"https://openalex.org/keywords/predictors-of-treatment-response","display_name":"predictors of treatment response","score":0.7170000076293945},{"id":"https://openalex.org/keywords/hcv-genotype-1b","display_name":"HCV genotype 1b","score":0.8299999833106995},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.6420000195503235},{"id":"https://openalex.org/keywords/viral-dynamics","display_name":"viral dynamics","score":0.7160000205039978},{"id":"https://openalex.org/keywords/hcv-core-antigen","display_name":"HCV core antigen","score":0.7730000019073486},{"id":"https://openalex.org/keywords/high-viral-load","display_name":"high viral load","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.8562678694725037},{"id":"https://openalex.org/C2777103181","wikidata":"https://www.wikidata.org/wiki/Q83141840","display_name":"NS5A","level":5,"score":0.7331814169883728},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.604954719543457},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6018511056900024},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5378109812736511},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.5312385559082031},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5220527648925781},{"id":"https://openalex.org/C2781463415","wikidata":"https://www.wikidata.org/wiki/Q2082778","display_name":"Hepacivirus","level":4,"score":0.40216556191444397},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39500224590301514},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.360710471868515},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3314005136489868}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012324","descriptor_name":"RNA-Dependent RNA Polymerase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014758","descriptor_name":"Viral Core Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017361","descriptor_name":"Viral Nonstructural Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018936","descriptor_name":"Hepatitis C Antigens","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D019943","descriptor_name":"Amino Acid Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/jmv.21438","doi":"https://doi.org/10.1002/jmv.21438","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jmv.21438","pdf_url":null,"source":{"id":"https://openalex.org/S49828768","display_name":"Journal of Medical Virology","issn_l":"0146-6615","issn":["0146-6615","1096-9071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medical Virology","raw_type":"journal-article"},{"id":"pmid:19235866","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19235866","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medical virology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W1964494489","https://openalex.org/W1968426124","https://openalex.org/W1971792395","https://openalex.org/W1978883570","https://openalex.org/W1979065789","https://openalex.org/W1982433898","https://openalex.org/W1985588212","https://openalex.org/W1992109850","https://openalex.org/W1992239172","https://openalex.org/W1995565071","https://openalex.org/W1999494993","https://openalex.org/W2010855805","https://openalex.org/W2016205218","https://openalex.org/W2024049300","https://openalex.org/W2027545702","https://openalex.org/W2033929071","https://openalex.org/W2046714103","https://openalex.org/W2046858735","https://openalex.org/W2059457521","https://openalex.org/W2066892848","https://openalex.org/W2071586067","https://openalex.org/W2075293916","https://openalex.org/W2075660007","https://openalex.org/W2079059990","https://openalex.org/W2084742492","https://openalex.org/W2088053309","https://openalex.org/W2096959824","https://openalex.org/W2105599476","https://openalex.org/W2107639148","https://openalex.org/W2108639262","https://openalex.org/W2112360308","https://openalex.org/W2121242678","https://openalex.org/W2122153421","https://openalex.org/W2122494591","https://openalex.org/W2127685726","https://openalex.org/W2133964987","https://openalex.org/W2141228361","https://openalex.org/W2145355617","https://openalex.org/W2150640672","https://openalex.org/W2150757291","https://openalex.org/W2158694627","https://openalex.org/W2159954692","https://openalex.org/W2166971952","https://openalex.org/W2169391152","https://openalex.org/W2317554121","https://openalex.org/W2335845212"],"related_works":["https://openalex.org/W1979065789","https://openalex.org/W1596381887","https://openalex.org/W1978883570","https://openalex.org/W1964232559","https://openalex.org/W2075660007","https://openalex.org/W2042149897","https://openalex.org/W4235533023","https://openalex.org/W1982593095","https://openalex.org/W2016205218","https://openalex.org/W2346868652"],"abstract_inverted_index":{"The":[0,88],"aim":[1],"of":[2,10,17,63,78,106,136,147,200,209,213,229,241],"this":[3],"study":[4,175],"was":[5,93,108,166],"to":[6,34,56,244],"compare":[7],"the":[8,36,79,83,97,104,112,164,195,203,207,235,245],"efficacy":[9],"high-dose":[11],"interferon":[12],"(IFN)-alpha-2b":[13],"with":[14,21,26,40,47,66,143,188,198,217,249],"standard":[15],"dose":[16,212],"IFN-alpha-2b":[18,65,214],"in":[19,96,111,163,169,185,194,202,215,226,234,247],"combination":[20,216],"ribavirin":[22],"(RBV)":[23],"for":[24,155],"patients":[25,46,141,187,248],"chronic":[27],"hepatitis":[28],"C":[29],"virus":[30],"(HCV)":[31],"infection,":[32],"and":[33,82,129,161,197,237,252],"investigate":[35],"predictive":[37,154,240],"factors":[38,69],"associated":[39],"virological":[41,90,138,170,222,242],"response.":[42,139],"Two":[43],"hundred":[44],"Japanese":[45],"high":[48,253],"HCV":[49,130,179],"viral":[50,173,254],"load":[51],"(>100":[52],"KIU/ml)":[53],"were":[54,70,133,153],"randomized":[55],"6":[57,117],"or":[58],"10":[59,113],"mega":[60],"units":[61],"(MU)":[62],"24-week":[64],"RBV.":[67],"Predictive":[68],"investigated;":[71],"including":[72],"pretreatment":[73],"amino":[74],"acid":[75,232],"(aa)":[76],"sequences":[77],"core":[80,148,180,196,236],"region":[81,86],"IFN-sensitive":[84],"determining":[85],"(ISDR).":[87],"sustained":[89,137],"response":[91,157,223,243],"rate":[92],"not":[94,220],"different":[95],"two":[98],"groups":[99],"(24%":[100],"vs.":[101,121],"30%)":[102],"but":[103,224],"incidence":[105,228],"depression":[107],"significantly":[109],"higher":[110,211,227],"MU":[114,118],"group":[115,119],"than":[116],"(7%":[120],"0%,":[122],"P":[123],"=":[124],"0.02).":[125],"Younger":[126],"age":[127],"(<60)":[128],"genotype":[131,144,250],"(2a/b)":[132],"significant":[134],"predictors":[135],"In":[140,205],"infected":[142],"1b,":[145],"substitutions":[146,162,193,201,233],"aa":[149,189],"70":[150,190],"and/or":[151,191],"91":[152,192],"non-virological":[156],"(P":[158],"<":[159],"0.001),":[160],"ISDR":[165,238],"observed":[167],"frequently":[168],"responders.":[171],"Early":[172],"kinetics":[174],"showed":[176],"that":[177],"serum":[178],"antigen":[181],"decreased":[182],"more":[183],"slowly":[184],"both":[186],"absence":[199],"ISDR.":[204],"conclusion,":[206],"use":[208],"a":[210],"RBV":[218],"did":[219],"improve":[221],"resulted":[225],"depression.":[230],"Amino":[231],"are":[239],"therapy":[246],"1b":[251],"load.":[255]},"counts_by_year":[{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}